400-921-8278
| Catalog_no | ADMC0052 |
| Product_name | I-BET151 (GSK1210151A) |
| Category | 抑制剂与激动剂 |
| Size | 10mg/50mg/100mg |
| Price | 1340.00/4000.00/7000.00 |
| Specificity | Target: Epigenetic Reader Domain. Fields: I-BET151 (GSK1210151A) is a novel selective BET inhibitor for BRD2, BRD3 and BRD4 with IC50 of 0.5 μM, 0.25 μM, and 0.79 μM, respectively. |
| Dilution | pIC50: 6.1 (BRD4), 6.3 (BRD2), 6.6 (BRD3)[1] |
| Purification | >98% |
| Concentration | 靶点：Epigenetic Reader Domain;IC50：p 6.1 (BRD4), 6.3 (BRD2), 6.6 (BRD3)[1] |
| Storage_stability | 2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO |
| othername | GSK-1210151A，IBET151，I-BET-151，I BET 151，IBET-151，IBET 151,GSK 1210151A |
| Observed_band | 415.44 |
| Notes | I-BET151 (GSK1210151A) is a novel selective BET inhibitor for BRD2, BRD3 and BRD4 with IC50 of 0.5 μM, 0.25 μM, and 0.79 μM, respectively. |
| Instructions | 
查看与下载 |
| Share |
 |
Copyright © 2021 苏州博特龙免疫技术有限公司 版权所有 ，苏ICP备2021013855号-1
苏公网安备32050702011981号 
